Fennec Pharmaceuticals Inc (FENC)

Fennec Pharmaceuticals Inc Azioni (FENC) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	154.94% 25.38	9.954	6.296	-12.51	1.582
Operating Expenses	7.05% 11.63	10.87	7.201	-7.843	6.852
Benefits Costs and Expenses	67.35% 12.54	38.41	-	-7.065	7.634
Costs And Expenses	67.35% 12.54	38.41	-	-7.843	6.852
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	855.94% 13.74	-1.818	-1.017	-4.666	-5.27
Net Interest Income/Expense	71.30% 0.197	0.115	0.102	-	-
Nonoperating Income/Loss	4.86% -0.906	-0.864	-0.85	-0.778	-0.782
Income/Loss From Continuing Operations Before Tax	145.11% 12.84	-28.46	6.296	-5.444	-6.052
Income/Loss From Continuing Operations After Tax	145.11% 12.84	-28.46	0.917	-5.444	-6.052
Net Income/Loss	145.11% 12.84	-28.46	0.917	-5.444	-6.052
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	52,929% 27.05	0.051	26.60	26.46	26.56
Diluted Average Shares	60,863% 31.09	0.051	26.60	26.46	26.56
Basic Earnings Per Share	415.38% 0.41	-0.13	-0.03	-0.21	-0.23
Diluted Earnings Per Share	415.38% 0.41	-0.13	-0.03	-0.21	-0.23
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-